Select Page
Acting Vice-Chancellor Statement on Gender Based Violence (GBV) and recent Xenophobic attacks

Acting Vice-Chancellor Statement on Gender Based Violence (GBV) and recent Xenophobic attacks

Women’s month was concluded on a very sad note in the country as we continued to witness violent acts against women and more recently at foreign nationals.

 

Gender Based Violence (GBV) is a serious societal problem confronting South African women including the Lesbian, gay and bisexual, transgender, queer, intersex and asexual (LGBTQIA+) communities – it is a menace. The recent tragic killing of Uyinene Mrwetyana, a student from University of Cape Town, as well as Jesse Hess from the University of the Western Cape provides a grim picture of how women continue to be victimized in our country on a daily basis.

 

More details can be accessed by following the download below:

Acting-Vice-Chancellor-Statement-Gender-Based-Violence-GBV-and-recent-Xenophobic-attacks

Acting Vice-Chancellor Statement – Academic Activities for the Week (9-13 September 2019)

Acting Vice-Chancellor Statement – Academic Activities for the Week (9-13 September 2019)

As the University enters a second week of mourning the passing of Hunadi Magongoa (MBChB II), we should all bow our heads in recognition of the immense contribution she has made to the SMU ladies soccer team as a gallant and devoted sportswoman of our times. Accordingly, while we await the outcome of the ongoing investigation by the state agencies on the suspected outbreak and cause of death, the University will continue to mourn her passing during the course of the week both on and off the academic spaces.

 

More details can be accessed by following the download below:

Acting-Vice-Chancellor-Statement-Academic-Activities-for-the-Week-9-13-September-2019

Learning how to save lives cost efficiently

Learning how to save lives cost efficiently

In the interest of ongoing professional development, Dr Tshimane Tshepuwane, in the department of Obstetrics and Gynaecology (DOG), along with SINAPI Biomedical, extended a joint invitation to Professor Gerhard Theron, to deliver a lecture on the use of the Ellavi Uterine Balloon Tamponade (Ellavi UBT).

 

A new device, Ellavi UBT became commercially available in the 3rd quarter of 2019 and it is being used to prevent child birth bleeding complications which results in the deaths of mothers. It is based on the glove balloon used in South Africa since 2008. Prof Gerhard Theron also described the Ellavi UBT in the Postpartum Haemorrhage Monograph published in 2010 by the National Committee for Confidential Enquiries into Maternal Deaths. This inventor, from the University of Stellenbosch, is a leading light in obstetrics and gynaecology, with many awards and many articles in peer review journals, to his name.

 

Watched by a captive audience of representatives of professional midwifery nurses, post-natal nurses, registrars, consultants, fourth year to final year Bachelor of Medicine and Bachelor of Surgery (MBChB) students, Theron meticulously demonstrated how to operate the Ellavi UBT.

 

Thereafter he gave a select group of consultants, registrars and professional midwives an opportunity to put into practice what they had learned in order to enable them to sharpen their newly acquired clinical skills.

 

Impressed with the Ellavi UBT and the ease with which the select group operated the device, Professor Sam Monokoane, the head of the DOG at SMU, expressed his wish to phase it in, at the Dr George Mukhari Academic Hospital, where students fulfil their clinical obligations.

 

On state tender the SOS Bakri costs R4800 per unit whilst the Ellavi UBT is R150 per unit for public hospitals. It is not on state tender, presently. The Ellavi UBT is affordable for use in resource poor settings.

 

Already, all hospitals in the three rural regions of the Western Cape Province, and half of the metropolitan areas of Cape Town served by Tygerberg Hospital as a referral hospital, are using Ellavi UBTs since the 1st quarter of 2019. Though no data is available regarding lives saved with Ellavi UBT.

 

About 90 papers published in peer reviewed scientific journals do report a success rate of 87% of the Ellavi UTB if used for the correct indications. A decline in death rates due to child birth bleeding complications following Caesarean births is to be expected if Ellavi UBT is to be used in all birthing facilities in South Africa.

 

By Maditsi Matlala

Council’s Statement on the passing of Hunadi Magongoa

Council’s Statement on the passing of Hunadi Magongoa

The Council of the University passes its deepest condolences to the family of Magongoa after the passing of Hunadi Magongoa reportedly from the food she consumed from the Student Cafeteria of the University. Management has instituted an investigation comprising multi-disciplinary experts to test the veracity of the allegations.

 

More details can be accessed by following the download below:

Councils-Statement-on-the-passing-of-Hunadi-Magongoa-September-4-2019-

Vice-Chancellor (Acting) Statement – Update on the developments on Campus and Investigation pertaining to the passing of Hunadi Mogongoa

Vice-Chancellor (Acting) Statement – Update on the developments on Campus and Investigation pertaining to the passing of Hunadi Mogongoa

As we continue to mourn the passing of Student Hunadi Magongoa (MBChB II), it is important to brief the University community about other developments on the campus and the status of investigation pertaining to the passing of our beloved student.

 

More details can be accessed by following the download below:

Acting-Vice-Chancellor-Statement-Update-on-the-developments-on-Campus-and-Investigation-pertaining-to-the-passing-of-Hunadi-Mogongoa-Sept-4-2019